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ABSTRACT
OBJECTIVE
To investigate the association of grip strength with 
disease specific incidence and mortality and whether 
grip strength enhances the prediction ability of an 
established office based risk score.
DESIGN
Prospective population based study.
SETTING
UK Biobank.
PARTICIPANTS
502 293 participants (54% women) aged 40-69 years.
MAIN OUTCOME MEASURES
All cause mortality as well as incidence of and 
mortality from cardiovascular disease, respiratory 
disease, chronic obstructive pulmonary disease, 
and cancer (all cancer, colorectal, lung, breast, and 
prostate).
RESULTS
Of the participants included in analyses, 13 322 
(2.7%) died over a mean of 7.1 (range 5.3-9.9) years’ 
follow-up. In women and men, respectively, hazard 
ratios per 5 kg lower grip strength were higher (all at 
P<0.05) for all cause mortality (1.20, 95% confidence 
interval 1.17 to 1.23, and 1.16, 1.15 to 1.17) and 
cause specific mortality from cardiovascular disease 
(1.19, 1.13 to 1.25, and 1.22, 1.18 to 1.26), all 
respiratory disease (1.31, 1.22 to 1.40, and 1.24, 
1.20 to 1.28), chronic obstructive pulmonary disease 
(1.24, 1.05 to 1.47, and 1.19, 1.09 to 1.30), all cancer 
(1.17, 1.13 to 1.21, 1.10, 1.07 to 1.13), colorectal 
cancer (1.17, 1.04 to 1.32, and 1.18, 1.09 to 1.27), 
lung cancer (1.17, 1.07 to 1.27, and 1.08, 1.03 to 
1.13), and breast cancer (1.24, 1.10 to 1.39) but not 
prostate cancer (1.05, 0.96 to 1.15). Several of these 
relations had higher hazard ratios in the younger age 
group. Muscle weakness (defined as grip strength <26 
kg for men and <16 kg for women) was associated with 
a higher hazard for all health outcomes, except colon 
cancer in women and prostate cancer and lung cancer 
in both men and women. The addition of handgrip 
strength improved the prediction ability, based on 
C index change, of an office based risk score (age, 
sex, diabetes diagnosed, body mass index, systolic 
blood pressure, and smoking) for all cause (0.013) 
and cardiovascular mortality (0.012) and incidence of 
cardiovascular disease (0.009).
CONCLUSION
Higher grip strength was associated with a range 
of health outcomes and improved prediction of an 
office based risk score. Further work on the use of grip 
strength in risk scores or risk screening is needed to 
establish its potential clinical utility.
Introduction
The main role of skeletal muscle is to control body 
movements through the generation of force. Skeletal 
muscle is also the primary protein store within the 
body and in chronic conditions, such as cancer, and it 
can provide gluconeogenic precursors that are crucial 
for survival as such conditions progress.1 In addition to 
this, skeletal muscle is the primary outlet for glucose 
disposal in the body and is therefore important in 
metabolic conditions such as diabetes.2 Muscle mass 
is also decreased (cachexia) in many conditions, such 
as cancer, respiratory disease, chronic kidney disease, 
and chronic infection and sepsis.3 With these broad 
physiological and functional roles, skeletal muscle has 
a critical, but often underrated, role in health.4
Many studies have shown that lower muscle function 
is associated with greater mortality and morbidity.5-14 
For example, in 1 142 599 male adolescents (age 
16-19 years) followed up over 24 years, low muscle 
strength was associated with higher all cause mortality 
and mortality from cardiovascular disease but not 
from cancer.8 Recent data from the Prospective Urban 
Rural Epidemiology (PURE) study (n=139 691 adults 
aged 35-70 years followed up for four years) showed 
that grip strength was inversely associated with all 
cause mortality and with non-cardiovascular and 
cardiovascular mortality, but no significant association 
was found with respiratory disease and chronic 
obstructive pulmonary disease.7 Moreover, lower grip 
strength was found to be positively associated with 
incident cancer in high income countries but not in 
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WhAT IS AlReAdy knoWn on ThIS TopIC
Grip strength has previously been found to be associated with health outcomes
WhAT ThIS STudy AddS
Higher grip strength was associated with a lower risk of all cause mortality and 
incidence of and mortality from cardiovascular disease, respiratory disease, 
chronic obstructive pulmonary disease, all cancer and sub-types of cancer
The associations were independent of confounders, but several of these 
associations were weaker in older age categories
Grip strength improved the prediction ability of an office based risk score, and 
muscle weakness is associated with poorer health outcomes and thus may have 
clinical utility
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middle or lower income countries. The authors of this 
study concluded that, although some data support 
an association between grip strength and mortality, 
further research is needed to confirm this association 
with other health outcomes.7
Therefore, clear evidence shows that low grip 
strength is associated with a range of poorer health 
outcomes.5-14 Furthermore, grip strength enhances 
prediction of mortality based on age (C index increase 
from 0.65 for age to 0.69 for age+grip strength) 
and sex (C index increase from 0.54 for sex to 0.63 
for sex+grip).14 However, whether the addition of 
handgrip strength to a traditional office based risk 
score (including age, sex, smoking, blood pressure, 
presence of diabetes, and body mass index15) improves 
risk prediction is unclear. Such analysis will allow us 
to determine whether measurement of grip strength 
has clinical utility for risk prediction in settings where 
blood based measures are not readily available (for 
example, community/rural settings or low/middle 
income countries).
A meta-analysis (53 476 participants) published in 
2010 showed that grip strength was associated with 
lower all cause mortality; the association seemed to 
be weaker in studies in which participants had an 
average age of 60 years or less, relative to those with 
a higher average age at baseline.6 The relatively small 
sample size in this analysis limited the ability to fully 
explore how associations vary with age. The Tromso 
study (6850 participants, age 50-80 years) found 
associations between low grip strength and mortality,5 
but no interaction with age was observed; again, 
power was limited by low participant numbers in this 
study. The large size of the UK Biobank cohort provides 
the opportunity to robustly determine whether the 
association between grip strength and health outcomes 
differs by age.
The aim of this study, therefore, was to investigate 
the associations of grip strength with all cause 
mortality and disease specific incidence and mortality, 
how these associations vary with age, and whether 
the addition of grip strength improves the prediction 
ability of established office based risk scores, in the UK 
Biobank, a very large, general population cohort.
Methods
Between April 2007 and December 2010, UK Biobank 
recruited 502 628 participants (5.5% response rate 
after invitation letters sent to around 9 million people), 
aged 40-69 years, from the general population.16 
Participants attended one of 22 assessment centres 
across England, Wales, and Scotland,17 18 where they 
completed a touch screen questionnaire, had physical 
measurements taken, and provided biological samples, 
as described in detail elsewhere.17 18 The outcomes in 
the study reported here were incidence of and mortality 
from cardiovascular disease, all respiratory disease, 
chronic obstructive pulmonary disease, all cancers, 
breast cancer, prostate cancer, colorectal cancer, and 
lung cancer, as well as all cause mortality, with the 
exposure variable being grip strength (age and sex 
specific quarters and 5 kg increase in grip strength). We 
treated sociodemographic factors (age, sex, ethnicity, 
and area based socioeconomic status), month of 
recruitment, smoking status, height, body mass index, 
and self reported physical activity, sedentary time, 
and dietary intake as potential confounders, as well as 
prevalent diabetes, hypertension, chronic obstructive 
pulmonary disease, depression, cancer, and 
longstanding illness at baseline (where participants 
with these conditions were not excluded from the 
analyses).
Procedures
Date of death and date and cause of hospital 
admissions were identified as described previously.19 
We defined incident cardiovascular disease as a 
hospital admission or death with ICD-10 (international 
classification of diseases, 10th revision) codes I60, I61, 
I63, I64, I21, I21.4, and I21.9. We defined respiratory 
disease as ICD-10 codes J09-J98 and I26-I27 and 
chronic obstructive pulmonary disease as ICD-10 code 
J44. We defined all cause cancer as an ICD-10 code of 
C0.0-C9.9, D3.7-9, or D4.0-8 recorded on the cancer 
registry, death certificate, or hospital admission. We 
defined cause specific cancers by using the following 
ICD-10 codes recorded on the cancer registry, death 
certificate, or hospital admission: breast cancer 
(C50), prostate cancer (C61), lung cancer (C34), and 
colorectal cancer (C18, C19, and C20).
Grip strength was measured as previously 
described,19 and the mean of the right and left values 
was expressed in absolute units (kg) for subsequent 
analysis. Physical activity was based on self report, 
using the International Physical Activity Questionnaire 
short form,20 and total physical activity was calculated 
as the sum of walking and moderate and vigorous 
activity, measured as metabolic equivalents (MET-
min/week). We derived total time spent in sedentary 
behaviours from the sum of self reported time spent 
driving, using a computer, and watching television.
Dietary information was collected via the Oxford 
WebQ, a web based 24 hour recall questionnaire that 
was developed specifically for use in large population 
studies.21 22 We derived area based socioeconomic 
status from the postcode of residence, using the 
Townsend score.23 We calculated age from dates 
of birth and baseline assessment. We categorised 
smoking status into never, former, and current 
smoking. We collected medical history (physician’s 
diagnosis of depression, stroke, angina, heart attack, 
hypertension, cancer, diabetes, hypertension, chronic 
obstructive pulmonary disease, or longstanding 
illness) from the self completed baseline assessment 
questionnaire. Trained nurses measured height and 
body weight during the initial assessment centre visit. 
We calculated body mass index as weight/height2 
and used the World Health Organization’s criteria 
to classify it into categories of underweight (<18.5), 
normal weight (18.5 to <25), overweight (25 to <30), 
obese (30 to <35), obesity class 2 (35 to <40), and 
obesity class 3 (≥40). Trained nurses measured body 
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composition (body fat and fat free mass) by using bio-
impedance. Further details of these measurements can 
be found in the UK Biobank’s online protocol (http://
www.ukbiobank.ac.uk).
Statistical analyses
We used multivariable cubic regression splines to 
visually explore non-linear associations between 
grip strength and health outcomes. As we found no 
evidence of deviation from linearity, we investigated 
the associations of grip strength with cause specific 
incidence and mortality over follow-up with Cox 
proportional hazard models. We reported the results as 
hazard ratios together with 95% confidence intervals. 
The models for incidence of and mortality from 
cardiovascular disease, respiratory disease, and cancer 
excluded participants with a history of cardiovascular 
disease (myocardial infarction, angina, or stroke), 
respiratory disease and chronic obstructive pulmonary 
disease, or cancer at baseline, respectively.
Firstly, we treated grip strength as a continuous 
variable and calculated hazard ratios per 5 kg 
decrement in grip strength for men and women 
separately. To enable comparability with other 
reports in the literature, we also calculated hazard 
ratios for age and sex specific quarters of grip 
strength (supplementary table A), with participants 
in the highest quarter for grip strength used as the 
reference group. We also did analyses using a sex 
specific cut-off point for clinically relevant muscle 
weakness (supplementary table B), as recommended 
by the Foundation for the National Institutes of Health 
Sarcopenia Project.24 We investigated potential sex 
interactions by fitting a multiplicative interaction term 
into the models between grip strength (kg) and sex; 
although we found no significant interactions for the 
effect of grip strength on health outcomes by sex, we 
have presented stratified analyses because levels of 
grip strength differ significantly between woman and 
men (supplementary table C).
For Cox proportional hazard analyses, we ran 
four models that included an increasing number of 
covariates: model 0 (minimally adjusted) included 
sociodemographic covariates (age, sex, ethnicity, 
Townsend index, and month of recruitment); model 
1 was adjusted as in model 0 but also included 
height; model 2 was adjusted as in model 1 but also 
included prevalent morbidity (hypertension, diabetes, 
depression, and longstanding illness, as well as 
cardiovascular disease, respiratory disease, and cancer 
when these were not the outcome); model 3 (fully 
adjusted) was adjusted as in model 2 but also included 
lifestyle factors (smoking status, body mass index 
categories, total physical activity, total sedentary time, 
and dietary intake of alcohol, fruit and vegetables, 
oily fish, red meat, and processed meat). To minimise 
the potential contribution of reverse causality to the 
findings, we did a landmark analysis excluding events 
occurring within the two years after recruitment in 
model 4 (landmark analysis). This landmark analysis 
was adjusted as in model 3.
We then investigated whether these associations 
differed by age by doing a two way interaction analysis 
and fitting a handgrip strength*age interaction term 
to our model. We then repeated our Cox proportional 
hazard analyses (models 3 and 4) stratified by age 
categories (≤55, 56-65, and >65 years).
To assess the predictive ability of handgrip strength, 
we calculated Harrell’s C index (which estimates the 
probability of concordance between observed and 
predicted responses25) for a model including office 
based risk factors such as age, sex, diabetes diagnosed, 
body mass index (per 5 units), systolic blood pressure 
(per 10 mm Hg), and smoking, and we then compared 
the ability to predict all cause mortality and incidence 
of and mortality from cardiovascular disease in this 
model with the addition of handgrip strength (per 5 
kg). To validate the predictive ability of grip strength, 
we divided the cohort into two subsets by using random 
sampling stratified by age (<60 and ≥60 years) and sex 
to ensure that the proportions of men and older adults 
were similar in both subsets. For the derivation set, we 
used sex adjusted models and then estimated C indices 
and 95% confidence intervals in the validation set.26 
In addition, we compared the magnitude of the hazard 
for all cause mortality and incidence of and mortality 
from cardiovascular disease associated with a 1 SD 
increment in handgrip strength and other well known 
modifiable risk factors—systolic blood pressure and 
total physical activity—for which the associations were 
also expressed per 1 SD increment.
We checked the proportional hazard assumption by 
tests based on Schoenfeld residuals. We used Stata 14 
statistical software for all analyses.
Patient involvement
No patients were involved in setting the research 
question or the outcome measures, nor were 
they involved in developing plans for design or 
implementation of the study. No patients were asked 
to advise on interpretation or writing up of results. 
There are no plans to disseminate the results of the 
research to study participants or the relevant patient 
community.
Results
Of the 502 628 participants recruited to UK Biobank, 
502 293 (99%) had data on grip strength. The mean 
follow-up period was 7.1 (range 5.3-9.9) years for all 
cause and cause specific mortality and 6.1 (4.4-9.0) 
years for cause specific incidence. Of the 502 293 
participants included in the respective analyses, over 
the follow-up period, 28 059 (5.6%) participants 
developed cardiovascular disease, 10 542 (2.1%) 
developed respiratory disease, and 27 704 (5.5%) 
developed cancer. In addition, 13 322 (2.7%) 
participants died: 3033 (0.6%) from cardiovascular 
disease, 2062 (0.4%) from respiratory disease, and 
5738 (1.1%) from cancer.
Table 1 summarises the main characteristics of the 
participants by quarters of grip strength. In summary, 
people in the lowest quarter for strength (Q1) were 
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from more deprived fifths and had a higher prevalence 
of current smoking, obesity, and comorbidities, 
including cancer, diabetes, cardiovascular disease, 
longstanding illness, depression, and hypertension, 
compared with the highest grip strength group (Q4). 
They had a lower height but higher body mass index, 
waist circumference, and percentage body fat; had 
lower intake of alcohol, fruit, and vegetables; and 
had lower levels of physical activity and higher levels 
of television viewing in comparison with those in the 
Table 1 | Characteristics of cohort by age and sex specific quarters of grip strength. Values are percentages (numbers) unless stated otherwise
Characteristics All (n=477 074)
Quarter of grip strength*
Q4 (highest) (n=113 177) Q3 (n=120 735) Q2 (n=121 439)
Q1 (lowest) 
(n=121 723)
Sociodemographics
Women 54.5 (260 063) 55.5 (62 777) 54.1 (65 338) 54.3 (65 943) 54.2 (66 005)
Mean (SD) age, years 56.5 (8.1) 55.7 (8.4) 56.5 (8.1) 56.7 (8.0) 57.1 (7.8)
Mean (SD) deprivation index −1.3 (3.1) −1.7 (2.9) −1.5 (2.9) −1.3 (3.1) −0.8 (3.3)
Fifths of deprivation index:
 Lowest 20.4 (97 082) 22.8 (25 749) 21.5 (25 931) 20.4 (24 714) 17.0 (20 688)
 Lower-middle 20.2 (96 263) 21.6 (24 458) 21.2 (25 504) 20.2 (24 477) 17.9 (21 824)
 Middle 20.1 (95 940) 20.5 (23 190) 20.6 (24 885) 20.3 (24 592) 19.1 (23 273)
 Middle-higher 19.9 (95 121) 19.1 (21 612) 19.5 (23 551) 20.0 (24 248) 21.1 (25 710)
 Highest 19.4 (92 668) 16.1 (18 168) 17.3 (20 864) 19.3 (23 408) 24.8 (30 228)
Ethnicity†:
 White 94.9 (451 146) 96.3 (108 717) 96.1 (115 725) 95.2 (115 303) 91.9 (111 401)
 Mixed background 1.4 (6851) 1.2 (1324) 1.2 (1496) 1.4 (1664) 2.0 (2367)
 South Asian 1.9 (8829) 0.5 (580) 1.0 (1217) 1.7 (2093) 4.1 (4939)
 Black 1.5 (7309) 1.8 (2051) 1.4 (1640) 1.4 (1630) 1.6 (1988)
 Chinese 0.3 (1412) 0.2 (174) 0.3 (309) 0.3 (396) 0.4 (533)
Smoking status:
 Never 55.0 (262 252) 54.3 (61 455) 54.7 (65 981) 54.4 (67 272) 55.5 (67 544)
 Previous 34.7 (165 467) 35.8 (40 562) 35.3 (42 571) 34.5 (41 874) 33.2 (40 460)
 Current 10.3 (49 355) 9.9 (11 160) 10.1 (12 183) 10.1 (12 293) 11.3 (13 719)
Obesity related markers
Mean (SD) height, m 1.68 (0.1) 1.70 (0.1) 1.69 (0.1) 1.67 (0.1) 1.66 (0.1)
Mean (SD) BMI 27.4 (4.8) 27.5 (4.6) 27.2 (4.6) 27.2 (4.7) 27.7 (5.1)
BMI categories:
 Underweight (<18.5) 0.5 (2482) 0.3 (334) 0.4 (535) 0.6 (671) 0.8 (942)
 Normal weight (18.5-<25.0) 32.8 (156 314) 31.1 (35 237) 33.6 (40 584) 34.3 (41 698) 31.9 (38 795)
 Overweight (25.0-<30.0) 42.5 (202 770) 44.0 (49 809) 43.3 (52 314) 42.2 (51 188) 40.6 (49 459)
 Obese (≥30.0) 24.2 (115 508) 24.6 (27 797) 22.6 (27 302) 23.0 (27 882) 26.7 (32 527)
Mean (SD) waist circumference, cm 90.2 (13.4) 90.2 (13.3) 89.7 (13.2) 89.8 (13.4) 91.1 (13.9)
Central obesity 33.4 (159 517) 33.4 (37 756) 31.6 (38 140) 32.0 (38 839) 36.8 (44 782)
Mean (SD) body fat, % 31.4 (8.5) 31.0 (8.4) 31.1 (8.4) 31.4 (8.5) 32.2 (8.7)
Physical activity
Mean (SD) grip strength, kg 30.7 (11.0) 39.6 (10.6) 33.3 (8.9) 28.7 (8.0) 21.7 (7.9)
Mean (SD) total physical activity, MET-min/week 2846.3 (3045.8) 3000.3 (3095.7) 2898.3 (3055.7) 2823.1 (2037.8) 2660.6 (2982.5)
Mean (SD) television viewing, h/day 2.8 (1.6) 2.6 (1.5) 2.7 (1.5) 2.8 (1.6) 3.0 (1.7)
Mean (SD) total discretionary sedentary behaviour, h/day 5.0 (2.3) 5.0 (2.2) 5.0 (2.2) 5.0 (2.3) 5.1 (2.4)
Mean (SD) dietary intakes
Total energy, kcal/day)‡ 2165 (668) 2196 (668) 2170 (656) 2154 (661) 2140 (685)
Protein, % of TE‡ 15.6 (3.6) 15.6 (3.6) 15.5 (3.6) 15.5 (3.6) 15.5 (3.7)
Total fat, % of TE‡ 32.1 (6.7) 32.2 (6.7) 32.0 (6.6) 32.0 (6.8) 32.0 (6.8)
Saturated fat, % of TE‡ 12.3 (3.3) 12.4 (3.3) 12.3 (3.3) 12.3 (3.3) 12.3 (3.4)
Carbohydrate, % of TE‡ 47.2 (8.2) 46.9 (8.1) 47.1 (8.1) 47.3 (8.2) 47.7 (8.4)
Sugar, % of TE‡ 22.5 (7.0) 22.5 (6.8) 22.5 (6.9) 22.5 (7.0) 22.6 (7.3)
Alcohol, % of TE‡ 5.2 (6.5) 5.3 (6.4) 5.3 (6.5) 5.2 (6.6) 4.8 (6.6)
Fruit and vegetables, g/day 330.0 (195.2) 336.2 (190.7) 332.4 (192.1) 327.0 (191.6) 324.7 (205.6)
Processed meat, portion/day 1.9 (1.1) 1.8 (1.0) 1.9 (1.1) 1.9 (1.1) 1.9 (1.1)
Red meat, portion/day 2.1 (1.4) 2.1 (1.4) 2.1 (1.4) 2.1 (1.4) 2.1 (1.5)
Oily fish, portion/day 1.1 (1.0) 1.1 (1.0) 1.1 (1.0) 1.1 (1.0) 1.1 (1.1)
Health status
Diabetes history 5.2 (24 911) 3.5 (4010) 4.3 (5126) 5.1 (6185) 7.9 (9590)
Cancer history 7.7 (36 564) 7.0 (7911) 7.4 (8925) 7.8 (9420) 8.5 (10 308)
Longstanding illness 32.4 (154 382) 26.1 (29 491) 28.7 (34 610) 31.7 (38 478) 42.6 (51 803)
Cardiovascular disease 29.4 (140 357) 26.8 (30 296) 27.9 (33 666) 29.2 (35 434) 33.7 (40 961)
Depression history 5.6 (26 616) 4.4 (5004) 5.0 (6090) 5.7 (6879) 7.1 (8643)
Hypertension 23.7 (113 191) 22.8 (25 745) 23.1 (27 836) 23.6 (28 596) 25.5 (31 014)
BMI=body mass index; MET=metabolic equivalent; TE=total energy intake.
*For cut-off points for age and sex specific quarters of grip strength, see supplementary table A.
†1527 participants reported “other” or “mixed ethnic” background.
‡Data for nutrient intakes were available for a subset of 211 064 participants.
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lowest grip strength group. The main characteristics 
by age specific quarters, stratified by sex, are shown in 
supplementary tables D and E.
As shown in figure 1, in both men and women, a 5 kg 
lower grip strength was associated with a higher hazard 
for all cause mortality and incidence of and mortality 
from cardiovascular disease, all respiratory disease, 
chronic obstructive pulmonary disease, all cancer, and 
colorectal, lung, and breast cancer in model 0. The 
associations were similar after adjustment for height 
in model 1; after further adjustment, the magnitude of 
associations were slightly attenuated in models 2, 3, 
and 4 (supplementary tables F-K). These associations 
remained significant for all cause specific mortality 
(fig 1) and incidence outcomes (fig 2), in both men and 
women in model 4. The mortality hazards per 5 kg lower 
grip strength (in model 4) observed were as follows: for 
all respiratory disease (hazard ratio 1.31 and 1.24 for 
women and men, respectively), chronic obstructive 
pulmonary disease (1.24 and 1.19), cardiovascular 
disease (1.19 and 1.24), and all cause mortality (1.20 
and 1.16), followed by breast cancer (1.24), colorectal 
cancer (1.17 and 1.18), lung cancer (1.17 and 1.08), 
and all cancer mortality (1.17 and 1.10). When we 
treated grip strength as an ordinal variable by using 
age specific quarters, we found similar results for all 
incidence and mortality outcomes in men and women, 
and grip strength was not significantly associated with 
prostate cancer mortality but was associated with 
incident prostate cancer (supplementary tables H-K).
We observed grip strength*age interactions in 
women for all cause mortality, all cancer mortality, 
cardiovascular disease incidence, chronic obstructive 
pulmonary disease incidence, all cancer incidence, 
and lung cancer incidence and in men for all cause 
mortality, cardiovascular disease mortality, all 
respiratory mortality, chronic obstructive pulmonary 
disease mortality, all cancer mortality, lung cancer 
mortality, cardiovascular disease incidence, chronic 
obstructive pulmonary disease incidence, all cancer 
incidence, lung cancer incidence, and prostate cancer 
incidence (supplementary tables L and M, model 
3). The hazard ratios were higher in the younger 
age categories. These interactions remained in our 
landmark analysis with events in the first two years 
excluded (supplementary tables N and O, model 4).
As shown in figure 3 and figure 4, and in 
supplementary tables P and Q, muscle weakness 
(defined as a grip strength ≤26.0 kg for men and ≤16.0 
kg for women) was associated with an increased risk 
of all health outcomes, except for both incidence of 
and mortality from colorectal cancer in women, lung 
cancer in both men and women, and prostate cancer 
in men. Using a previously established office based 
(non-laboratory) risk score,15 which includes age, sex, 
smoking, blood pressure, diabetes, and body mass 
index, we investigated whether the prediction ability of 
this risk score was improved when handgrip strength 
was added into the score. Our results showed that 
the traditional office based score had good predictive 
abilities for all cause mortality and incidence of 
and mortality from cardiovascular disease (table 2). 
Adding grip strength significantly improved prediction 
compared with the office based score alone (changes 
in Harrell’s C statistics versus the conventional risk 
score were 0.013 for all cause mortality, 0.012 for 
cardiovascular disease mortality, and 0.009 for 
incident cardiovascular disease) (table 2). Both the risk 
scores performed well in the derivation and validation 
cohorts (table 2).
Data presented as C index and 95% CI and as 
differences in C index versus reference model. Reference 
model includes information on age, sex, body mass 
index (5 units), systolic blood pressure (10 mm Hg), 
history of diabetes, and smoking. Handgrip strength 
was added into model as 5 kg decrease in grip strength. 
Analyses were performed in derivation cohort and then 
in randomly selected internal validation cohort (~50% 
of cohort balanced by sex). Then Harrell’s C statistic 
was calculated in both derivation cohort (n=219 087) 
and validation cohort (n=218 852).
In view of the significant improvement in the 
prediction ability between handgrip strength and all 
cause mortality, cardiovascular disease mortality, and 
incident cardiovascular disease, we did a post hoc 
comparison of the associated hazard of grip strength 
All cause mortality 
  Women
  Men 
Cardiovascular disease mortality 
  Women
  Men 
Respiratory mortality 
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Fig 1 | Hazard for all cause and cause specific mortality per 5 kg lower grip strength 
stratified by sex. Data presented as adjusted hazard ratio and 95% CI by 5 kg decrease 
in grip strength. Analyses were adjusted for age, deprivation index, ethnicity, month 
of recruitment, comorbidities (depression, diabetes, hypertension, longstanding 
illness, respiratory diseases, cancer, and cardiovascular disease), height, body mass 
index categories, smoking, physical activity, sedentary behaviour, and dietary intake 
(alcohol, fruit and vegetables, oily fish, red meat, and processed meat) and excluding 
events in first two years after recruitment (model 4). COPD=chronic obstructive 
pulmonary disease
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with systolic blood pressure (a robust modifiable 
risk factor for premature death) and total physical 
activity (supplementary table R). After adjustment, 
grip strength showed the strongest association, 
per 1 SD change, with all cause and cardiovascular 
disease mortality (hazard ratio 1.48 and 1.57 per 1 
SD lower grip strength, respectively) in comparison 
with systolic blood pressure (1.03 and 1.26) and total 
physical activity (1.06 and 1.07). However, for incident 
cardiovascular disease, the hazard associated with a 1 
SD change in strength and systolic blood pressure was 
of a similar magnitude (hazard ratio 1.29 and 1.30, 
respectively). We found no associations between total 
physical activity and incident cardiovascular disease 
(supplementary table R).
discussion
The main finding of this study is that lower grip 
strength was strongly associated with a wide range of 
adverse health outcomes. The associations observed 
were consistent between sexes and remained robust 
after adjustment for deprivation, ethnicity, and several 
other health, lifestyle, and dietary factors. For several 
adverse health outcomes, we observed interactions with 
age, with the risk associated with lower grip strength 
modestly stronger in younger age groups. Moreover, 
our results provide evidence that the addition of grip 
strength can improve the prediction ability of an office 
based risk score for all cause mortality and incidence 
of and mortality from cardiovascular disease. 
These findings could have important public health 
implications, as grip strength in comparison with 
other physical measures, specifically cardiorespiratory 
fitness and physical activity, is easily measured, cheap, 
and highly reproducible in clinical practice.27 We found 
that grip strength had a stronger association with all 
cause and cardiovascular disease mortality than do 
systolic blood pressure or total physical activity, and 
that the strength of associations for grip strength with 
incidence of cardiovascular disease was similar to 
that for systolic blood pressure and stronger than for 
total physical activity. Grip strength may, therefore, 
be a useful method of identifying people with muscle 
weakness who are at high risk of a wide range of 
diseases and who might benefit from further health 
assessments of risk for vascular and non-vascular 
outcomes.
Comparisons with other studies
The finding of an inverse association between grip 
strength and mortality is consistent with previous 
studies.5-13 Our finding of a hazard ratio for all cause 
mortality of 1.16 for men and 1.20 for women, for a 5 
kg lower grip strength, in our fully adjusted model, is 
in agreement with observations from the PURE study 
of 139 691 participants, which reported that a 5 kg 
lower grip strength was, after adjustment, associated 
with a hazard ratio of 1.16 for all cause mortality.7 
Furthermore, our findings for all cause mortality are 
also comparable to those reported in the meta-analysis 
of Cooper et al for all cause mortality (hazard ratio for 
a 5 kg lower grip strength of 1.16, after adjustment 
for sex, height, and body mass index).6 The inverse 
association between grip strength and cardiovascular 
disease mortality seen in our study is also of a similar 
magnitude to findings reported previously. For 
example, in the PURE study a 5 kg lower grip strength 
was, after adjustment, associated with a hazard ratio of 
1.17 for cardiovascular mortality.7 The fully adjusted 
hazard ratio in our study, per 5 kg lower grip strength, 
for cardiovascular disease mortality was 1.22 for men 
and 1.19 for women.
Our data on the associations between grip strength 
and cancer do, however, differ from previously 
published studies and, importantly, provide novel 
results for specific types of cancer. In the recent 
report of Strand et al,5 a 1 standard deviation lower 
grip strength was, after adjustment, associated with 
a hazard ratio of 1.05 for cancer mortality. This is 
similar to our finding that a 5 kg (equivalent to about 
0.5 SD) lower grip strength was associated, in the fully 
adjusted model, with a hazard ratio of 1.10 for men and 
1.17 for women. However, in the PURE study,7 a 5 kg 
lower grip strength was, after adjustment, associated 
with a hazard ratio of 0.95 for all cancer outcomes, in 
high income countries but not in middle or low income 
countries. The reason for these differential findings is 
not clear but, as pointed out by Leong and colleagues,7 
they merit further investigation and examination of 
different cancer subtypes. We have extended limited 
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Fig 2 | Hazard for cause specific incidence per 5 kg lower grip strength stratified by sex. 
Data presented as adjusted hazard ratio and 95% CI by 5 kg decrease in grip strength. 
Analyses were adjusted for age, deprivation index, ethnicity, month of recruitment, 
comorbidities (depression, diabetes, hypertension, longstanding illness, respiratory 
diseases, cancer, and cardiovascular disease), height, body mass index categories, 
smoking, physical activity, sedentary behaviour, and dietary intake (alcohol, fruit and 
vegetables, oily fish, red meat, and processed meat) and excluding events in first two 
years after recruitment (model 4)
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evidence in this area and shown that grip strength is 
inversely associated with mortality from colorectal 
(hazard ratio 1.18 and 1.17) and lung cancer (1.08 
and 1.17) in men and women, respectively, and 
breast cancer in women (1.24). Although we found no 
association between grip strength and prostate cancer 
mortality, a positive association existed between 
strength and incidence of prostate cancer. The reason 
for this is not clear, but it may reflect people with higher 
grip strength being more health conscious and more 
readily visiting their doctor—thus the association with 
incidence but not mortality. Whether this is the case 
remains to be established. Some of these hazard ratios 
are, although significant, relatively small, particularly 
for cancer, and whether these are clinically significant 
and also not the result of reverse causality (see further 
discussion below) remains to be established.
Clinical potential
The association between grip strength and health 
outcomes has been extensively studied, but whether 
measurement of grip strength in health screening 
settings has clinical utility has been unclear. It has 
previously been shown that grip strength enhances risk 
prediction for all cause mortality on top of the prediction 
seen with age or sex alone.13 14 Neither of the studies, 
however, was able to investigate whether the addition 
of handgrip strength to an established office based risk 
score (including age, sex, diabetes diagnosed, body 
mass index, systolic blood pressure, and smoking) 
improves prediction of all cause or cardiovascular 
disease mortality, for which several interventions to 
reduce risk are possible. Our data showed that handgrip 
strength improves the prediction ability of this model. 
The magnitude of improvement with the addition of 
grip strength (C index change=0.013) is similar to that 
seen when adding high density lipoprotein cholesterol 
and N-terminal pro b-type natriuretic peptide (C index 
change 0.007 for high density lipoprotein and 0.020 
for N-terminal pro b-type natriuretic peptide, for a 
composite outcome of coronary heart disease plus stroke 
and heart failure) to conventional risk factor scores 
(age, sex, smoking, systolic blood pressure, history 
of diabetes, and concentration of total cholesterol).28 
Thus, our findings suggest that measurement of 
handgrip strength—which is easily measured objectively 
and highly reproducible in clinical practice27—in risk 
screening settings where blood sampling is not possible 
(for example, in community settings or in low and 
middle income countries) may add clinical utility over 
existing risk prediction scores.
In addition, we have shown that, using previously 
derived cut-offs,24 muscle weakness is associated with 
an increased risk of most health outcomes studied, the 
only exceptions being colorectal cancer (women), lung 
cancer (both men and women), and prostate cancer 
(men). These data complement the aforementioned 
change in C index and support the use of these grip 
strength thresholds to indicate muscle weakness and 
thus identify high risk populations.
Whether the associations between health outcomes 
and grip strength are consistent across age categories 
has rarely been investigated. A meta-analysis 
including 53 476 participants from 14 studies 
suggested that the association between grip strength 
and mortality seemed to be weaker in people aged 
60 years or less, relative to older participants, but an 
interaction with age was not formally tested owing to 
the low number of studies.6 Another investigation of 
6850 participants found no interaction between grip 
strength and age for mortality, probably owing to the 
relatively low participant numbers. Our analysis of 
more than 500 000 participants provided sufficient 
power for us to robustly determine interactions 
between grip strength and age for health outcomes, 
showing that grip strength was significantly associated 
with health outcomes across the age range of the UK 
Biobank population, but that these associations were 
moderately stronger, not weaker, in the younger age 
groups. This possibly indicates that with age, factors, 
in addition to grip strength, that influence health 
become more important. We are, however, unable to 
determine the reasons underlying these differences 
in associations with age, and further work should 
investigate this.
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Fig 3 | Hazard for all cause and cause specific mortality in women and men by FNIH 
Sarcopenia cut-off points for muscle weakness. Data presented as adjusted hazard 
ratio and 95% CI by FNIH Sarcopenia cut-off points (reference groups ≥26.0 kg for men 
and ≥16.0 kg for women). Analyses were adjusted for age, deprivation index, ethnicity, 
month of recruitment, comorbidities (depression, diabetes, hypertension, longstanding 
illness, respiratory diseases, cancer, and cardiovascular disease), height, body mass 
index categories, smoking, physical activity, sedentary behaviour, and dietary intake 
(alcohol, fruit and vegetables, oily fish, red meat, and processed meat) and excluding 
events in first two years after recruitment (model 4). COPD=chronic obstructive 
pulmonary disease
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Handgrip strength correlates strongly to leg muscle 
strength and provides a valid marker of overall 
limb muscle strength throughout the age range.29 
It has been suggested that handgrip strength is a 
marker for nutritional status,30 and analysis from the 
Hertfordshire Cohort Study has shown that a healthier 
(“prudent diet”) pattern of eating and consumption of 
dietary protein, antioxidant nutrients, vitamin D, and 
fatty fish is associated with grip strength.31 Previous 
work has also shown that people who are more 
physically active and have lower sedentary time have 
a higher grip strength.32-35 Thus, lifestyle factors are 
clearly important in the maintenance of grip strength. 
Ethnicity, age, sex, height, and socioeconomic status 
have also been shown to be associated with grip 
strength,31 36-38 and handgrip strength has a strong 
genetic component with heritability shown to be 
52%.39 With so many factors contributing to handgrip 
strength, determining the mechanisms that fully 
underlie the association between handgrip strength 
and health outcomes is not possible, but they are 
probably multifactorial in nature and are worthy of 
further investigation.
Limitations of study
The UK Biobank is not representative of the general 
population of the UK in several ways. It is relatively 
representative of the general UK population in 
terms of age, sex, ethnicity, and socioeconomic 
status but is only partially representative in terms of 
lifestyle. Therefore, caution is needed in generalising 
summary statistics to the general population, but 
estimates of the magnitude of the associations are, 
nevertheless, generalisable. Participants were more 
likely to be older, to be women, and to live in less 
socioeconomically deprived areas; were less likely 
to be obese, to smoke, or to drink alcohol on a daily 
basis; and had fewer self reported health outcomes. 
Rates of all cause mortality and incidence of cancer 
were also lower.16 40 Our study had sufficient power 
to allow subgroup analyses by age, which overcomes 
limitations from previous studies. Reverse causality 
is possible in any observational study; although our 
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Fig 4 | Hazard for cause specific incidence in women and men by FNIH Sarcopenia 
cut-off points for muscle weakness. Data presented as adjusted hazard ratio and 95% 
CI by FNIH Sarcopenia cut-off points (reference groups ≥26.0 kg for men and ≥16.0 
kg for women). Analyses were adjusted for age, deprivation index, ethnicity, month 
of recruitment, comorbidities (depression, diabetes, hypertension, longstanding 
illness, respiratory diseases, cancer, and cardiovascular disease), height, body mass 
index categories, smoking, physical activity, sedentary behaviour, and dietary intake 
(alcohol, fruit and vegetables, oily fish, red meat, and processed meat) and excluding 
events in first two years after recruitment (model 4)
Table 2 | Improvement in risk discrimination for all cause mortality and cardiovascular disease outcomes by addition 
of handgrip strength to model with conventional office based risk factors
C index (95% CI) C index change (95% CI) P value
All cause mortality
Derivation cohort:
 Conventional office based risk factors 0.722 (0.717 to 0.727) 0.013 (0.011 to 0.015) <0.001 Plus handgrip strength 0.735 (0.730 to 0.740)
Validation cohort:
 Conventional office based risk factors 0.722 (0.717 to 0.728) 0.012 (0.011 to 0.014) <0.001 Plus handgrip strength 0.734 (0.729 to 0.740)
Cardiovascular disease mortality
Derivation cohort:
 Conventional office based risk factors 0.788 (0.774 to 0.801) 0.012 (0.007 to 0.017) <0.001 Plus handgrip strength 0.800 (0.786 to 0.913)
Validation cohort:
 Conventional office based risk factors 0.787 (0.773 to 0.800) 0.011 (0.005 to 0.017) <0.001 Plus handgrip strength 0.799 (0.785 to 0.812)
Cardiovascular disease incidence
Derivation cohort:
 Conventional office based risk factors 0.736 (0.730 to 0.743) 0.009 (0.007 to 0.010) <0.001 Plus handgrip strength 0.745 (0.739 to 0.751)
Validation cohort:
 Conventional office based risk factors 0.737 (0.730 to 0.743)
0.009 (0.007 to 0.011) <0.001 Plus handgrip strength 0.746 (0.740 to 0.751)
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results were similar after a landmark analysis of 
events occurring from two years after recruitment, 
we cannot exclude the possibility of reverse causality. 
Similarly, residual confounding is always possible and 
the associations observed may not imply causality. 
However, given that we are largely interested in 
prediction and identification of people at increased 
risk, and not seeking to make strong causal inferences, 
reverse causality is not a major limitation.
Conclusions
This study has shown that grip strength is strongly 
and inversely associated with all cause mortality and 
incidence of and mortality from cardiovascular disease, 
respiratory disease, chronic obstructive pulmonary 
disease, all cancer, and subtypes of cancer, including 
colorectal, lung, and breast cancer, with associations 
being modestly stronger in the younger age groups. 
Our results show that adding handgrip strength to an 
existing office based risk score improves the prediction 
ability for all cause mortality and incidence of and 
mortality from cardiovascular disease and that muscle 
weakness (using previously defined grip strength 
cut-offs) is associated with poorer health outcomes. 
This indicates that the addition of the measurement 
of grip strength may be useful in screening for 
risk of cardiovascular disease in community/rural 
settings and in developing countries where access to 
biochemical measurements (such as total cholesterol) 
is not possible. Further work is needed to define how to 
use grip strength in this manner, in particular in non-
British populations.
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